AstraZeneca and CSPC Sign Up to $18.5 Billion Ex-China Weight Management Collaboration

February 4, 2026

Ascidian & Lilly Pen RNA Exon Editing Agreement for Genetic Kidney Issues

June 9, 2026

Rocket abandons its attempt to obtain FDA approval for bone marrow gene therapy

October 7, 2025

Must Read

Phase 3 of Merck and Moderna’s customized cancer vaccine lowers recurrence, paving the way for approval

August 21, 2026

FDA Issues Warning Letters to Aurobindo’s Eugia Unit and Tianjin Kilo Pharmaceutical

August 21, 2026

Novo Launches Late-Stage Trial of Lower-Dose Wegovy Pill for Weight Management

August 21, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Novo Launches Late-Stage Trial of Lower-Dose Wegovy Pill for Weight Management

Oregon Study Finds Triple-Drug Regimen Kept Infant Macaques HIV-Free for One Year

Summit and Akeso Report Updated HARMONi Survival Data for Ivonescimab in Western NSCLC Patients

ARPA-H Awards Up to $160 Million for Personalized Genetic Medicine Development

Biokin’s Iza-Bren Meets Primary Endpoint in Phase 3 Panku-Lung01 Lung Cancer Trial

Definium Bags Major Phase 3 Victory With LSD Formula

Taiho and Cullinan Report Phase 3 Progression-Free Survival Win for Zipalertinib

MoonLake Reports Positive Phase 3 Results for Sonelokimab in Psoriatic Arthritis

Leo Pharma Pens Mega Deal to Buy Tanabe’s Skin Disease Drug

PTC Therapeutics Acquires ST-920 Fabry Disease Gene Therapy Program From Sangamo

Zealand Bags Huge Money By Selling Rights to Takeda’s Blood Cancer Drug

Claryx Appears From Stealth to Deal with the $45B Hospital-Acquired Infections Issue

J&J’s OTTAV Robotic Surgical System has received FDA market authorization in the U.S.

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

Quantum Computing and Drug Discovery

Why Data Is Becoming Pharma’s Most Valuable Asset

Reinventing the Pharmaceutical Commercial Model

Top 10 Strategic Priorities for Pharma CEOs in 2027

Tag: Definium

Definium Bags Major Phase 3 Victory With LSD Formula

Editor Picks

AstraZeneca and CSPC Sign Up to $18.5 Billion Ex-China Weight Management Collaboration

Ascidian & Lilly Pen RNA Exon Editing Agreement for Genetic Kidney Issues

Rocket abandons its attempt to obtain FDA approval for bone marrow gene therapy

Must Read

Phase 3 of Merck and Moderna’s customized cancer vaccine lowers recurrence, paving the way for approval

FDA Issues Warning Letters to Aurobindo’s Eugia Unit and Tianjin Kilo Pharmaceutical

Novo Launches Late-Stage Trial of Lower-Dose Wegovy Pill for Weight Management

Hot Topics

About Us

Follow Us